RedHill Biopharma Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
IL0011223810
Pharmaceuticals
Sales 2022 | 61.8M 22.88B | Sales 2023 | 6.53M 2.42B | Capitalization | 28.72M 10.64B |
---|---|---|---|---|---|
Net income 2022 | -71M -26.29B | Net income 2023 | 23M 8.52B | EV / Sales 2022 | 1.87 x |
Net Debt 2022 | 103M 38.03B | Net cash position 2023 | 4.4M 1.63B | EV / Sales 2023 | 3.73 x |
P/E ratio 2022 |
-0.12
x | P/E ratio 2023 |
0.4
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 09-08-02 |
Ori Shilo
FOU | Founder | 58 | 09-08-02 |
Razi Ingber
DFI | Director of Finance/CFO | - | 23-01-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 15-12-31 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 10-08-25 |
Director/Board Member | 80 | 10-05-02 |
1st Jan change | Capi. | |
---|---|---|
-3.79% | 87.06B | |
+1.45% | 40.25B | |
-16.21% | 31.09B | |
+52.66% | 24.74B | |
-14.29% | 15.91B | |
-9.12% | 11.96B | |
-14.95% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B |